Friedemann Honecker

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Disease markers

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of cancer research and clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ekaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz, Christine Jacobsen, Jessica Hauschild, Tina Rohlfing, Alexandra Sergeevna Silchenko, Sergey A Avilov, Stefan Balabanov, Carsten Bokemeyer, Dmitry L Aminin, Gunhild von Amsberg, Friedemann Honecker
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A 2 -2 in Human Prostate Cancer Cells. Marine drugs 22 (1) (2023)
Ekaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz, Christine Jacobsen, Jessica Hauschild, Tina Rohlfing, Alexandra Sergeevna Silchenko, Sergey A Avilov, Stefan Balabanov, Carsten Bokemeyer, Dmitry L Aminin, Gunhild von Amsberg, Friedemann Honecker
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A 2 -2 in Human Prostate Cancer Cells. Marine drugs 22 (1) (2023)
Ekaterina S Menchinskaya, Sergey A Dyshlovoy, Simone Venz, Christine Jacobsen, Jessica Hauschild, Tina Rohlfing, Alexandra Sergeevna Silchenko, Sergey A Avilov, Stefan Balabanov, Carsten Bokemeyer, Dmitry L Aminin, Gunhild von Amsberg, Friedemann Honecker
Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A 2 -2 in Human Prostate Cancer Cells. Marine drugs 22 (1) (2023)
Dennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, Lambert C J Dorssers, Ad J M Gillis, Silvia Schmidtova, Katarina Kalavska, Harmen J G van de Werken, Christoph Oing, Friedemann Honecker, Michal Mego, Leendert H J Looijenga
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Sergey A Dyshlovoy, Friedemann Honecker
Marine Compounds and Cancer: Updates 2020. Marine drugs 18 (12) (2020)
Sergey A Dyshlovoy, Friedemann Honecker
Marine Drugs Acting as Autophagy Modulators. Marine drugs 18 (1) (2020)
Felix Bremmer, Hanibal Bohnenberger, Stefan Küffer, Thomas Oellerich, Hubert Serve, Henning Urlaub, Arne Strauss, Yasmine Maatoug, Carl Ludwig Behnes, Christoph Oing, Heinz Joachim Radzun, Philipp Ströbel, Stefan Balabanov, Friedemann Honecker
Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines. Disease markers 2019 (2019)
Sergey A Dyshlovoy, Friedemann Honecker
Marine Compounds and Cancer: The First Two Decades of XXI Century. Marine drugs 18 (1) (2019)
Martin Fenner, Christoph Oing, Annette Dieing, Thomas Gauler, Karin Oechsle, Anja Lorch, Marcus Hentrich, Hans-Georg Kopp, Carsten Bokemeyer, Friedemann Honecker
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group. Journal of cancer research and clinical oncology 145 (3) (2018)
Sergey A Dyshlovoy, Friedemann Honecker
Marine Compounds and Cancer: 2017 Updates. Marine drugs 16 (2) (2018)
Christoph Oing, Izudin Verem, Wael Yassin Mansour, Carsten Bokemeyer, Sergey A Dyshlovoy, Friedemann Honecker
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells. International journal of molecular sciences 20 (1) (2018)
Sergey A Dyshlovoy, Friedemann Honecker
Marine Compounds and Autophagy: Beginning of a New Era. Marine drugs 16 (8) (2018)